Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine 5% TDS Irritation Study: Grader vs Imaging
NCT02787356Withdrawn
- Sponsor
- SRI International
- Start
- Oct 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
01
Overview
Randomised trial of lidocaine in postherpetic neuralgia (PHN) (2 arms), sponsored by SRI International. Primary endpoint: Assessing Accuracy of Berger & Bowman Dermal Response Scores Predicted from Images of Skin at 3 months. Planned start Oct 2017; status: withdrawn.
02
Drugs
lidocaine
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT02787356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02787356.